Researchers gather for stem cell retreat

November 8, 2013 by Carolyn Pennington

Scientists from across the state are gathering for a retreat at the Health Center today to present their latest findings in the field of stem cell research. Among those making presentations include researchers from UConn, Yale, Wesleyan, The Jackson Laboratory, and Pfizer pharmaceuticals.

Significant findings have been made since 2005, when the General Assembly first passed legislation committing $100 million for stem cell research over 10 years. The initiative has helped support major scientific advances, state-of-the-art research facilities, and the creation of new jobs.

Marc Lalande, director of the UConn Stem Cell Institute, told the gathering that with the state's investment, UConn has been able to grow a successful stem cell community with over 40 labs and more than 70 investigators.

"We've been able to develop technology and increase economic development that is being spurred by ," explained Lalande, "and that is extremely important given the investment the state is making in Bioscience Connecticut."

Lalande went on to say that "induced pluripotent stem (iPS) cells revolutionized by allowing us to make patient specific . The UConn Stem Cell Core lab manager, Leann Crandall, has made over a 100 of these stem cells lines and has sent them all over the world. So we're extremely proud of the technology we've developed which I think is cutting edge."

This video is not supported by your browser at this time.

Among the presenters at the retreat was Dr. Ren-He Xu, director of the UConn Stem Cell Core. He discussed "Correction of a Genetic Disease in Human Stem Cells," specifically involving his research into Marfan syndrome. Using "genetic editing" techniques, Xu is getting closer to identifying potential drug therapies that could help Marfan patients.

Explore further: Predicting the fate of stem cells

Related Stories

Predicting the fate of stem cells

October 22, 2013

University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will turn into. The technology could have potential use in regenerative medicine and drug development. ...

Scientists isolate new human pluripotent stem cells

October 31, 2013

One of the obstacles to employing human embryonic stem cells for medical use lies in their very promise: They are born to rapidly differentiate into other cell types. Until now, scientists have not been able to efficiently ...

Why stem cells need to stick with their friends

November 7, 2013

Scientists at University of Copenhagen and University of Edinburgh have identified a core set of functionally relevant factors which regulates embryonic stem cells' ability for self-renewal. A key aspect is the protein Oct4 ...

Recommended for you

Researchers design first artificial ribosome

July 29, 2015

Researchers at the University of Illinois at Chicago and Northwestern University have engineered a tethered ribosome that works nearly as well as the authentic cellular component, or organelle, that produces all the proteins ...

Studies reveal details of error correction in cell division

July 29, 2015

Cell biologists led by Thomas Maresca at the University of Massachusetts Amherst, with collaborators elsewhere, report an advance in understanding the workings of an error correction mechanism that helps cells detect and ...

Researchers discover new type of mycovirus

July 29, 2015

Researchers, led by Dr Robert Coutts, Leverhulme Research Fellow from the School of Life and Medical Sciences at the University of Hertfordshire, and Dr Ioly Kotta-Loizou, Research Associate at Imperial College, have discovered ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.